343 related articles for article (PubMed ID: 36417578)
1. Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance.
Rui Y; Eppler HB; Yanes AA; Jewell CM
Adv Healthc Mater; 2023 Jan; 12(6):e2202238. PubMed ID: 36417578
[TBL] [Abstract][Full Text] [Related]
2. Engineering Immune Tolerance with Biomaterials.
Gammon JM; Jewell CM
Adv Healthc Mater; 2019 Feb; 8(4):e1801419. PubMed ID: 30605264
[TBL] [Abstract][Full Text] [Related]
3. Cell and biomaterial delivery strategies to induce immune tolerance.
Scotland BL; Shaw JR; Dharmaraj S; Caprio N; Cottingham AL; Joy MartÃn Lasola J; Sung JJ; Pearson RM
Adv Drug Deliv Rev; 2023 Dec; 203():115141. PubMed ID: 37980950
[TBL] [Abstract][Full Text] [Related]
4. Biomaterial-based approaches to engineering immune tolerance.
Emerson AE; Slaby EM; Hiremath SC; Weaver JD
Biomater Sci; 2020 Dec; 8(24):7014-7032. PubMed ID: 33179649
[TBL] [Abstract][Full Text] [Related]
5. Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps.
Carey ST; Bridgeman C; Jewell CM
Adv Sci (Weinh); 2023 Mar; 10(8):e2205105. PubMed ID: 36638260
[TBL] [Abstract][Full Text] [Related]
6. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
Froimchuk E; Carey ST; Edwards C; Jewell CM
Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
[TBL] [Abstract][Full Text] [Related]
7. Engineering tolerance using biomaterials to target and control antigen presenting cells.
Tostanoski LH; Gosselin EA; Jewell CM
Discov Med; 2016 May; 21(117):403-10. PubMed ID: 27355336
[TBL] [Abstract][Full Text] [Related]
8. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.
Lasola JJM; Kamdem H; McDaniel MW; Pearson RM
Front Immunol; 2020; 11():1726. PubMed ID: 32849612
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance.
Kishimoto TK; Maldonado RA
Front Immunol; 2018; 9():230. PubMed ID: 29515571
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials for antigen-specific immune tolerance therapy.
Park J; Wu Y; Li Q; Choi J; Ju H; Cai Y; Lee J; Oh YK
Drug Deliv Transl Res; 2023 Jul; 13(7):1859-1881. PubMed ID: 36094655
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the liver to induce antigen-specific immune tolerance.
Gottwick C; Carambia A; Herkel J
Semin Immunopathol; 2022 Jul; 44(4):475-484. PubMed ID: 35513495
[TBL] [Abstract][Full Text] [Related]
12. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.
Shah SA; Oakes RS; Jewell CM
Adv Drug Deliv Rev; 2024 Jun; 209():115315. PubMed ID: 38670230
[TBL] [Abstract][Full Text] [Related]
13. Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity.
Northrup L; Christopher MA; Sullivan BP; Berkland C
Adv Drug Deliv Rev; 2016 Mar; 98():86-98. PubMed ID: 26546466
[TBL] [Abstract][Full Text] [Related]
14. In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.
Pearson RM; Casey LM; Hughes KR; Miller SD; Shea LD
Adv Drug Deliv Rev; 2017 May; 114():240-255. PubMed ID: 28414079
[TBL] [Abstract][Full Text] [Related]
15. Cationic nanoparticles-based approaches for immune tolerance induction in vivo.
Mao K; Wang J; Xie Q; Yang YG; Shen S; Sun T; Wang J
J Control Release; 2024 Feb; 366():425-447. PubMed ID: 38154540
[TBL] [Abstract][Full Text] [Related]
16. Tackling autoimmunity with nanomedicines.
Feng X; Liu J; Xu W; Li G; Ding J
Nanomedicine (Lond); 2020 Jul; 15(16):1585-1597. PubMed ID: 32669025
[TBL] [Abstract][Full Text] [Related]
17. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
18. Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.
Samojlik MM; Stabler CL
Acta Biomater; 2021 Oct; 133():87-101. PubMed ID: 34102338
[TBL] [Abstract][Full Text] [Related]
19. Antigen-Specific Tolerization and Targeted Delivery as Therapeutic Strategies for Autoimmune Diseases.
Shakya AK; Nandakumar KS
Trends Biotechnol; 2018 Jul; 36(7):686-699. PubMed ID: 29588069
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases.
Benne N; Ter Braake D; Stoppelenburg AJ; Broere F
Front Immunol; 2022; 13():864403. PubMed ID: 35392079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]